.AstraZeneca has discussed a very early consider the performance of its own in-house antibody-drug c...
.After revealing a period 3 launch based on favorable midstage results, iTeos and also GSK are actua...
.The FDA should be actually even more open and collective to discharge a rise in commendations of un...
.It's an unusually occupied Friday for biotech IPOs, with Zenas BioPharma, MBX as well as Bicara Reh...
.Atea Pharmaceuticals' antiviral has failed another COVID-19 trial, yet the biotech still stores out...
.Neurocrine Biosciences' schizophrenia course pivot has actually stopped working. The biotech was ac...
.Sanofi has actually created an overdue entrance to the radioligand gathering, paying 100 million eu...
.After F2G's first effort to receive a new course of antifungal to market was actually derailed due ...
.Moderna has vowed to reduce R&D costs through $1.1 billion by 2027. The decision to shrink the b...
.Just 4 months after Sanofi wager $80 thousand in upfront cash money on Key Therapies' losmapimod, t...